IMMUNOCELLULAR THERAPEUTICS's ticker is IMUC and the CUSIP is 452536105. A total of 39 filers reported holding IMMUNOCELLULAR THERAPEUTICS in Q4 2013. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 4 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 4 | -99.8% | 0.00% | – |
| Q3 2015 | $1,000 | -99.4% | 2,504 | -99.3% | 0.00% | – |
| Q2 2015 | $173,000 | +440.6% | 367,628 | +450.0% | 0.00% | – |
| Q1 2015 | $32,000 | 0.0% | 66,846 | +51.7% | 0.00% | – |
| Q4 2014 | $32,000 | -77.8% | 44,064 | -72.9% | 0.00% | – |
| Q3 2014 | $144,000 | -15.3% | 162,854 | +6.5% | 0.00% | – |
| Q2 2014 | $170,000 | +36.0% | 152,854 | +49.1% | 0.00% | – |
| Q1 2014 | $125,000 | – | 102,504 | +98461.5% | 0.00% | – |
| Q4 2013 | $0 | -100.0% | 104 | -99.7% | 0.00% | – |
| Q3 2013 | $102,000 | – | 40,004 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Callan Capital, LLC | 70,000 | $65,000 | 0.02% |
| Wellington Shields Capital Management, LLC | 51,000 | $47,000 | 0.01% |
| Ifrah Financial Services, Inc. | 18,500 | $17,000 | 0.01% |
| CHELSEA COUNSEL CO | 28,000 | $26,000 | 0.01% |
| DRW Securities, LLC | 120,000 | $111,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 66,303 | $61,000 | 0.00% |
| OPPENHEIMER & CO INC | 107,000 | $99,000 | 0.00% |
| First Allied Advisory Services, Inc. | 45,000 | $42,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $65,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 160,103 | $148,000 | 0.00% |